
»ù±¾ÇéÐÎ
½ð¾²Î¬£¬£¬ÄУ¬£¬½Î÷·á³ÇÈË£¬£¬Öй²µ³Ô±¡£¡£¡£ÏÖÈÎÒ¼ºÅÓéÀÖAPPҩѧÓëʳÎ﹤³ÌѧԺרÈÎÎ÷ϯ¡£¡£¡£
ÁªÏµ·½Ê½
µØµã£º£º£º¹ã¶«Ê¡½ÃÅÊÐÅî½Çø¶«³É´å22ºÅ Ò¼ºÅÓéÀÖAPPҩѧÓëʳÎ﹤³ÌѧԺ
Óʱࣺ£º£º529020
ÓÊÏ䣺£º£ºwyuchemjjw@126.com
ÊÂÇéÂÄÀú
2017Äê7ÔÂÖÁ½ñ£¬£¬Ò¼ºÅÓéÀÖAPP£¬£¬Ò©Ñ§ÓëʳÎ﹤³ÌѧԺ£¬£¬Ë¶Ê¿Éúµ¼Ê¦
2018Äê10ÔÂÖÁ2020Äê10Ô£¬£¬Ò¼ºÅÓéÀÖAPP£¬£¬½ÃÅÊд󿵽¡¹ú¼ÊÁ¢ÒìÑо¿Ôº£¬£¬²©Ê¿ºó
½ÌÓý¼°Ñ§Ï°ÂÄÀú
2013Äê9ÔÂ-2018Äê6Ô£¬£¬ÖÐɽ´óѧ»¯Ñ§Ñ§Ôº£¬£¬²©Ê¿
2010Äê9ÔÂ-2013Äê6Ô£¬£¬ÖÐɽ´óѧÉúÃü¿ÆÑ§Ñ§Ôº£¬£¬Ë¶Ê¿
2006Äê9ÔÂ-2010Äê 6Ô£¬£¬³¤´ºÊ¦·¶´óѧÉúÃü¿ÆÑ§Ñ§Ôº£¬£¬Ñ§Ê¿
Ö÷ÒªÑо¿Æ«Ïò
Ö÷Òª´Óʲ¡Ô΢ÉúÎï¡¢ÃâÒßѧ¡¢·Ö×ÓÉúÎïѧÓ뻯ѧµÄ½»Ö¯Ñ§¿ÆÑо¿£¬£¬Ö÷ÒªÑо¿Æ«ÏòΪÒßÃç×ô¼ÁºÍÒ©ÎïÔØÌåÉúÎïÖÊÁϵÄÉè¼ÆºÍÖÆ±¸ÒÔ¼°×ÔÈ»²úƷȪԴ¿¹Ñ×Ö¢¡¢¿¹Ö×Áö¡¢¿¹¹ÇÖÊËÉÉ¢ºÍÃâÒß»îÐÔ·Ö×ÓµÄɸѡºÍ×÷ÓûúÖÆÑо¿¡£¡£¡£»£»£½Ó´ý¶Ô´ËÑо¿Æ«Ïò¸ÐÐËȤµÄ˶ʿÑо¿ÉúºÍ±¾¿ÆÉú¼ÓÈë¡£¡£¡£
¿ÆÑÐÏîÄ¿
[1] ×ÔÈ»²úƷȪԴµÄÃâÒßµ÷Àí»îÐÔÒßÃç×ô¼Á·Ö×ÓµÄɸѡ¼°×÷ÓûúÖÆÑо¿£¬£¬Ò¼ºÅÓéÀÖAPP¸ßÌõÀíÒý½øÈË²ÅÆô¶¯¾·Ñ£¬£¬2021.01-2026.01£¬£¬100Íò£¬£¬Ö÷³Ö
[2] ÒùÑòÞ½´ÎÜÕ I ÒßÃç×ô¼ÁµÄÃâÒßµ÷Àí×÷Óü°»úÖÆÑо¿£¨81901678£©£¬£¬¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð£¬£¬2020.01-2022.12£¬£¬21 Íò£¬£¬Ö÷³Ö£¬£¬½áÌâ
½ÒÏþѧÊõÂÛÎÄ
[1] Pei-Qi Huang#, Kai-Wen Kang#, Dan-Yu Huang, Chun-Lin Zhao, Hao Zheng, Yong-Xin Luo, Yan Wen, Ming-Feng Zou, Dong-Li Li, Ri-Hui Wu, Yun-Cai Tian, Yong Tian, Wen-Huan Zhang, Jing-Wei Jin*, Sheng Yin*, Li-She Gan*. Lignan glucosides from Gentiana macrophylla with potential anti-arthritis and hepatoprotective activities. Phytochemistry, 2024, 217: 113920
[2] Ou Yi#, You Zonglin#, Yao Min, Cao Yingfan, Xue Xiu, Chen Min, Wu Rihui, Gan Lishe, Li Dongli, Wu Panpan, Xu Xuetao, Wong Wingleung, Wong Vincent Kam Wai, Liu Wenfeng*, Ye Jiming*, Jin Jingwei*. Naproxen-derived new compound inhibits the NF-¦ÊB, MAPK and PI3K/Akt signaling pathways synergistically with resveratrol in RAW264.7 Cells. Molecules, 2023, 28(8): 3395
[3] Yang Li#, Yajiao Jian#, Fan Xu, Yongxin Luo, Zhixuan Li, Yi Ou, Yan Wen, Jingwei Jin*, Chuanrui Zhang*, Lishe Gan*. Five new terpenoids from Viburnum odoratissimum var. sessiliflorum. Chinese Journal of Natural Medicines, 2023, 21(4): 298-307
[4] Tu Borong#, Liang Jinfeng#, Ou Yi, Zhang Xinyue, Zheng Wende, Wu Rihui, Gan Lishe, Li Dongli, Lu Yujing, Wu Jiaqiang, Hong WeiqianDavid , Zhang Kun, Wu Panpan*, Jin Jingwei*, Wong Wing-Leung*. Novel 18¦Â-glycyrrhetinic acid derivatives as a Two-in-One agent with potent antimicrobial and anti-inflammatory activity. Bioorganic Chemistry, 2022, 122: 105714
[5] Jin Jingwei#, He Hao#, Zhang Xinyue, Wu Rihui, Gan Lishe, Li Dongli, Lu Yujing, Wu Panpan*, Wong Wing-Leung*, Zhang Kun*. The in vitro and in vivo study of oleanolic acid indole derivatives as novel anti-inflammatory agents: Synthesis, biological evaluation, and mechanistic analysis, Bioorganic Chemistry, 2021, 113: 104981
[6] Jin Jingwei, Rong Minzhi*, Zhang Mingqiu*, Wong Wing-Leung*. Preparation of a water soluble aminated ¦Â-1,3-D-glucan for gene carrier: The in vitro study of the anti-inflammatory activity and transfection efficiency, Journal of Biomedical Materials Research Part A, 2021, 109(12): 2506-2515
[7] Jin Jingwei#, Hou Jinqiang#, Long Wei, Zhang Xinyue, Lu Yu-Ling, Li Dongli, Zhang Kun, Wong Wing-Leung*. Synthesis of fluorescent G-quadruplex DNA binding ligands for the comparison of terminal group effects in molecular interaction: phenol versus methoxybenzene, Bioorganic Chemistry, 2020, 99:103821
[8] Jin Jingwei#, Wu Panpan#, Zhang Xinyue, Li Dongli, Wong Wing-Leung*, Lu Yu-Ling*, Sun Ning*; Zhang Kun. Understanding the interaction of estrogenic ligands with estrogen receptors: a survey of the functional and binding kinetic studies, Journal of Environmental Science and Health, Part C, 2020, 38(2): 142-168
[9] Jin Jingwei, Tang Shunqing, Rong Minzhi*, Zhang Mingqiu*. Synergistic effect of dual targeting vaccine adjuvant with aminated ¦Â-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses. Acta Biomaterialia, 2018, 78: 211-223
[10] Jin Jingwei, Peng Weili, Tang Shunqing, Rong Minzhi*, Ming Zhangqiu*. Antigen uptake and immunoadjuvant activity of pathogen-mimetic hollow silica particles conjugated with ¦Â-glucan. Journal of Materials Chemistry B, 2018, 6: 6288-6301
[11] ½ð¾²Î¬£¬£¬Âí±£»£»£»ª£¬£¬ÇñË÷ƽ£¬£¬Áè±ò±ù£¬£¬ÀîºØ£¬£¬ºúÏþ±ù£¬£¬²ÜÓÀ³¤£¬£¬Ñ¦´ºÒË. ¿ÚÌãÒß²¡¶¾½âÐýøºãÎÂÀ©Ôö¼ì²âÒªÁìµÄ½¨Éè. ¹óÖÝÐóÄÁÊÞÒ½£¬£¬2014, 38 (5):1-5
[12] ½ð¾²Î¬£¬£¬Áõ¼ÒÈ«£¬£¬ÎâÈÕ»Ô£¬£¬¸ÊÀñÉ磬£¬ÀÀû£¬£¬ÁõÀÚ. ÆÑ¿û×Ó¶àÌǵÄÌáÈ¡¡¢ÊèÉ¢ºÍ±íÕ÷¡ª¡ª¡°Ê³ÎïÆÊÎöʵÑ顱¿Î³ÌÁ¢ÒìʵÑéÉè¼Æ. ¹ã¶«»¯¹¤£¬£¬2023£¬£¬50£¨18£©£º£º£º225-228
¼ÓÈëѧÊõ¾Û»á¼°ÂÛÎÄ
½ð¾²Î¬£¬£¬ÈÝÃôÖÇ£¬£¬ÕÂÃ÷Ç£¬ÌÀ˳Çå. ÉúÎïÖÊÁÏÓÃË®ÈÜÐÔ°·»¯½ÍĸÆÏ¾ÛÌǵÄÖÆ±¸. 2015 ÄêÌìϸ߷Ö×ÓѧÊõÂÛÎı¨¸æ»á£¬£¬BP-004£¬£¬2015Äê10ÔÂ17ÈÕ-21ÈÕ£¬£¬ËÕÖÝ
ÉêÇë¼°ÊÚȨרÀû
[1] ½ð¾²Î¬£¬£¬ÁõÇ£¬Áõ¼ÒÈ«£¬£¬¸ÊÀñÉ磬£¬ÀÀû£¬£¬ÎâÈÕ»Ô. Ò»ÖÖÅ£´óÁ¦¶àÌǵÄÖÆ±¸ÒªÁì¼°ÆäÔÚ¿¹¹ÇÖÊËÉÉ¢Ò©ÎïÖеÄÓ¦ÓÃ. Öйú·¢Ã÷רÀûÉêÇëºÅ£º£º£º202311545157.8, ÉêÇëÈÕÆÚ£º£º£º2023Äê11ÔÂ20ÈÕ
[2] ½ð¾²Î¬£¬£¬Â¬Ñåö£¬£¬ÁõÇ£¬Áõ¼ÒÈ«£¬£¬¸ÊÀñÉ磬£¬ÀÀû£¬£¬ÎâÈÕ»Ô. ÆÑ¿û×ÓÌáÈ¡ÎïÔÚÖÆ±¸¿¹¹ÇÖÊËÉÉ¢Ö¢ÖÆÆ·ÖеÄÓ¦ÓÃ. Öйú·¢Ã÷רÀûÉêÇëºÅ£º£º£º202311555583.X, ÉêÇëÈÕÆÚ£º£º£º2023Äê11ÔÂ21ÈÕ
[3] ½ð¾²Î¬£¬£¬Ò¦Ãô£¬£¬Áõ¼ÒÈ«£¬£¬ÀÀû£¬£¬¸ÊÀñÉ磬£¬ÎâÈÕ»Ô£¬£¬Â¬Ñåö£¬£¬»ÆÓÀ˜Å. ÆÑ¿û×ÓÌáÈ¡ÎïÔÚÖÆ±¸Ô¤·ÀºÍ/»òÖÎÁÆÂýÐԽ᳦Ñ×Ò©ÎïÖеÄÓ¦ÓÃ. Öйú·¢Ã÷רÀûÉêÇëºÅ£º£º£º202311241662.3, ÉêÇëÈÕÆÚ£º£º£º2023Äê9ÔÂ25ÈÕ
[4] ½ð¾²Î¬£¬£¬Ò¦Ãô£¬£¬Îâ¾´Ó꣬£¬Áõ¼ÒÈ«£¬£¬ÀÀû£¬£¬¸ÊÀñÉ磬£¬ÎâÈÕ»Ô£¬£¬»ÆÓÀ˜Å. ÆÑ¿û×ÓÌáÈ¡ÎïÔÚÖÆ±¸Ìá¸ß»úÌåÃâÒßÁ¦ÖÆÆ·ÖеÄÓ¦ÓÃ. Öйú·¢Ã÷רÀûÉêÇëºÅ£º£º£º202311247804.7, ÉêÇëÈÕÆÚ£º£º£º2023Äê9ÔÂ25ÈÕ
[5] ½ð¾²Î¬£¬£¬Â¬Ñåö£¬£¬ÀÀû£¬£¬¸ÊÀñÉ磬£¬ÎâÈÕ»Ô£¬£¬Ò¶¼½Ã÷£¬£¬ÕÔÐü. Ò»ÖÖÌáÈ¡×éÖ¯»òϸ°ûÖиÊÓÍÈýõ¥µÄÒªÁì. Öйú·¢Ã÷רÀûÉêÇëºÅ£º£º£º202310628534.8, ÉêÇëÈÕÆÚ£º£º£º2023Äê5ÔÂ30ÈÕ
[6] ½ð¾²Î¬£¬£¬ÁõÇ£¬Å·Ò壬£¬ÓÎ×ÚÁØ£¬£¬Ò¦Ãô£¬£¬³ÂÀ¼Ç࣬£¬ÁõÎķ棬£¬ÎâÈÕ»Ô£¬£¬¸ÊÀñÉ磬£¬ÀÀû. ÀÒ°±ËáøÒÖÖÆ¼Á¼°ÆäÔÚÖÆ±¸ÖÎÁÆÐþÉ«ËØÁöÒ©ÎïÖеÄÓ¦ÓÃ. Öйú·¢Ã÷רÀûÉêÇëºÅ£º£º£º202211330973.2, ÉêÇëÈÕÆÚ£º£º£º2022Äê10ÔÂ27ÈÕ. ÒÑÊÚȨ
[7] ½ð¾²Î¬£¬£¬Å·Ò壬£¬ÓÎ×ÚÁØ£¬£¬Ò¦Ãô£¬£¬ÁõÇ£¬ÁõÎķ棬£¬ÎâÈÕ»Ô£¬£¬¸ÊÀñÉ磬£¬ÀÀû. ÝÁÆÕÉú-Èâ¹ðËáÑÜÉúÎï¼°ÆäÔÚÖÆ±¸ÖÎÁÆLPSÓÕµ¼Ñ×Ö¢Ò©ÎïÖеÄÓ¦ÓÃ.Öйú·¢Ã÷רÀûÉêÇëºÅ£º£º£º202210895672.8, ÉêÇëÈÕÆÚ£º£º£º2022Äê7ÔÂ27ÈÕ
[8] ½ð¾²Î¬£¬£¬ÕÅܰÔ£¬£¬»ÆÓÀ˜Å£¬£¬ÀÀû£¬£¬ÕÅŸj. Ò»ÖÖ RAW 264.7 ϸ°ûÑ×֢ģ×ӵĽ¨ÉèÒªÁì.Öйú·¢Ã÷רÀûÉêÇëºÅ£º£º£º202010784949.0, ÉêÇëÈÕÆÚ£º£º£º2020Äê8 ÔÂ6ÈÕ
[9] ½ð¾²Î¬£¬£¬ÁÖ¶°È¨£¬£¬»ÆÓÀ˜Å£¬£¬ÀÀû£¬£¬ÕÅŸj. ´úÉÃÌпµÄ¿ìËÙ¼ì²âÒªÁì. Öйú·¢Ã÷רÀûÉêÇëºÅ£º£º£º201910631936.7£¬£¬ÉêÇëÈÕÆÚ£º£º£º2019Äê7ÔÂ12ÈÕ
[10] ½ð¾²Î¬£¬£¬ÁÖ¼Ò»Ô£¬£¬»ÆÓÀ˜Å£¬£¬ÀÀû£¬£¬ÕÅŸj. ¸£ÃÀË«µÄ¿ìËÙ¼ì²âÒªÁì. Öйú·¢Ã÷רÀûÉêÇëºÅ£º£º£º201910631200.X£¬£¬ÉêÇëÈÕÆÚ£º£º£º2019Äê7ÔÂ12ÈÕ
[11] ÈÝÃôÖÇ£¬£¬½ð¾²Î¬£¬£¬ÕÂÃ÷Çï. Ò»ÖÖ¸ºÔØ¿¹ÔµÄË®ÈÜÐÔ°·»¯¦Â-1,3-D-ÆÏ¾ÛÌÇÄÉÃ×Á£×Ó¼°ÆäÖÆ±¸ÒªÁìºÍÓ¦ÓÃ, 2020-07-14, Öйú, ZL201810145959.2. ÒÑÊÚȨ
[12] ÈÝÃôÖÇ£¬£¬½ð¾²Î¬£¬£¬ÕÂÃ÷Çï. Ò»ÖÖ¦Â-1,3-D-ÆÏ¾ÛÌÇÐÞÊεķÂÉúÖпնþÑõ»¯¹è¸´ºÏÁ£×Ó¼°ÆäÓ¦ÓÃ, 2020-10-23, Öйú, ZL201810445055.1. ÒÑÊÚȨ
»ñ½±¼°ÉùÓþ
±¾¿ÆÊ±´ú£º£º£º»ñµÃÁ½´Î¹ú¼ÒÀøÖ¾½±Ñ§½ð¡¢Á½´ÎѧԺһµÈ½±Ñ§½ð¡¢Ò»´ÎѧԺ¶þµÈ½±Ñ§½ð¡¢´óѧÉúËØÖÊÑø³É¹¤³ÌA¼¶ÉùÓþÖ¤ÊéºÍÓÅÒì½áÒµÉú³Æºô
Ñо¿Éúʱ´ú£º£º£º»ñµÃгÏѧÉúÓÅÒìÂÛÎĽ±Ñ§½ð